# EVALECGcardio Study

Study · id `cardio:ct-nct04468477` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04468477](<https://clinicaltrials.gov/study/NCT04468477>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04468477

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 750 participants.

## Technical summary

Registry record NCT04468477. Non-randomized; no masking; primary purpose diagnostic. Start 2020-05-29 (actual); primary completion 2021-05-21 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 750 participants (planned count; ClinicalTrials.gov record NCT04468477, source copy `cardio:ctgov-nct04468477-2020-07-13`, retrieved 2026-10-26)
- Started: 2020-05-29 (actual) (ClinicalTrials.gov record NCT04468477, source copy `cardio:ctgov-nct04468477-2020-07-13`, retrieved 2026-10-26)
- Primary completion: 2021-05-21 (anticipated) (ClinicalTrials.gov record NCT04468477, source copy `cardio:ctgov-nct04468477-2020-07-13`, retrieved 2026-10-26)
- Completion: 2021-05-21 (anticipated) (ClinicalTrials.gov record NCT04468477, source copy `cardio:ctgov-nct04468477-2020-07-13`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT04468477, source copy `cardio:ctgov-nct04468477-2020-07-13`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04468477-2020-07-13`, retrieved 2026-10-26)

## The registry's words

- Brief title: EVALECGcardio Study
- Condition: Cardiac Arrhythmia
- Intervention (Device): 6 Lead ECG
- Lead sponsor: The Leeds Teaching Hospitals NHS Trust
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as the lead sponsor: The Leeds Teaching Hospitals NHS Trust (`cardio:org-the-leeds-teaching-hospitals-nhs-trust`)

## Provenance

Content hash: 0522b273abcd45e9066727052140076c14cd8588a7780b4a6a811f83ef56d1c6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
